Search results
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 4 hours agoIt takes a long time.” A potential avenue for relief is to make a GLP-1 drug in pill form. Lilly has...
Drugs gang guilty of ammonia attack murder
BBC via AOL· 10 hours agoHis killers were also found guilty of orchestrating and carrying out three other similar chemical attacks in the days before his death, one of which led...
Drug ‘kingpin’ receives two life sentences for trafficking 2,000 kilos of cocaine from Mexico to GA
WSB Cox articles via Yahoo News· 3 days agoIn Dec. 2018, DEA agents received information from a confidential source that Ross was moving a...
San Francisco drug crackdown in Tenderloin producing results
CBS News· 4 hours agoSan Francisco is shifting its strategy in the crackdown on open air drug markets in the Tenderloin....
Hunter Biden agrees to drop lawsuit against Rudy Giuliani, court records show
Reuters via Yahoo News· 3 hours agoU.S. President Joe Biden's son, Hunter Biden, agreed to drop a lawsuit against Rudy Giuliani and...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 10 hours agoNovavax is expected to turn a profit in the second quarter as sales accelerate sequentially. Though,...
Ex-US Customs officer convicted of letting drug-filled cars enter from Mexico
KAAL Austin· 8 hours agoA former U.S. Customs officer has been convicted of accepting bribes to let drug-filled vehicles...
AbbVie inks immune disorder drug licensing deal with China's FutureGen
Reuters via Yahoo News· 16 hours agoAbbVie has been counting on its newer immunology medicines to help make up for declining sales of...
Teen killed during ‘drug transaction’ identified
Las Vegas Review-Journal· 9 hours agoA 15-year-old boy fatally wounded in northeast Las Vegas during what police classified as a “drug transaction” earlier this month was identified...
Canaccord maintains Buy rating on Quanterix stock amid AD drug news By Investing.com
Investing.com· 2 days agoOn Wednesday, Canaccord Genuity (TSX:CF) sustained its Buy rating and $25.00 price target for...
